The National Vaccine Advisory Committee, which provides guidance to the Department of Health and Human Services on vaccine use and safety, has received an updated charter that substantially redirects its focus and composition.
The new charter, dated July 7 but not widely publicized by HHS, introduces several significant changes to how the committee operates. Previously, NVAC consisted primarily of vaccine scientists, physicians, and public health officials tasked with recommending the safest and most effective vaccine deployment strategies for preventing infectious diseases. Under the revised charter, the committee is being instructed to expand its scope beyond vaccination alone to encompass alternative interventions for controlling the spread of vaccine-preventable diseases among populations unable or unwilling to receive immunizations.
These alternative approaches specified in the new charter include promoting healthy lifestyles, incorporating dietary supplements, and exploring what the document terms the “repurposed use” of drugs already approved by the FDA. The revisions also call for reducing the proportion of committee members who conduct industry-funded vaccine research, while increasing representation from members of the general public.
The charter changes come despite indications of White House guidance directing the shelving of vaccine policy modifications ahead of midterm elections. The effort to reshape NVAC represents one of several recent initiatives by health secretary Robert F. Kennedy Jr.’s team aimed at fundamentally restructuring how vaccination policy is established and reviewed within the federal government.